Literature DB >> 19185061

Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma.

Meeyoung Lee1, Soyoung Kim, Ok-Kyoung Kwon, Sei-Ryang Oh, Hyeong-Kyu Lee, Kyungseop Ahn.   

Abstract

Asthma is an inflammatory disease of the airways, and the current focus in managing asthma is the control of inflammation. Resveratrol (3,4,5-trihydroxystilbene) is a polyphenolic stilbene found in the skins of red fruits, including grapes, that may be responsible for some of the health benefits ascribed to consumption of red wine. We investigated the suppressive effects of resveratrol on asthmatic parameters such as cytokine release, eosinophilia, airway hyperresponsiveness, and mucus hypersecretion, in an OVA-induced allergic mouse model of asthma. Resveratrol significantly inhibited increases in T-helper-2-type cytokines such as IL-4 and IL-5 in plasma and bronchoalveolar lavage fluid (BALF), and also effectively suppressed airway hyperresponsiveness, eosinophilia, and mucus hypersecretion, in the asthmatic mouse model. The efficacy of resveratrol was similar to that of dexamethasone, a glucocorticoid used as a positive control. These results suggest that resveratrol may have applications in the treatment of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185061     DOI: 10.1016/j.intimp.2009.01.005

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  47 in total

Review 1.  Regulation of SIRT1 in cellular functions: role of polyphenols.

Authors:  Sangwoon Chung; Hongwei Yao; Samuel Caito; Jae-Woong Hwang; Gnanapragasam Arunachalam; Irfan Rahman
Journal:  Arch Biochem Biophys       Date:  2010-05-05       Impact factor: 4.013

2.  Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.

Authors:  Na Zang; Xiaohong Xie; Yu Deng; Shengde Wu; Lijia Wang; Caijing Peng; Simin Li; Ke Ni; Yan Luo; Enmei Liu
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury.

Authors:  Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium.

Authors:  Nathan S Alexander; Neal Hatch; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2011-04-07       Impact factor: 3.325

5.  Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.

Authors:  Bradford A Woodworth
Journal:  Laryngoscope       Date:  2015-05-06       Impact factor: 3.325

Review 6.  Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

Review 7.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  The effect of synthetic salidroside on cytokines and airway inflammation of asthma induced by diisocyanate (TDI) in mice by regulating GATA3/T-bet.

Authors:  Jing Wang; Lu Xiao; Lingpeng Zhu; Mei Hu; Qiujuan Wang; Tianhua Yan
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells.

Authors:  Devon Shirley; Cody McHale; Gregorio Gomez
Journal:  Biochim Biophys Acta       Date:  2016-01-14

10.  Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR.

Authors:  Ying Jai; Kalpit Shah; Robert J Bridges; Neil A Bradbury
Journal:  Biochim Biophys Acta       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.